BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Nomoto H. Fixed-ratio combinations of basal insulin and glucagon-like peptide-1 receptor agonists as a promising strategy for treating diabetes. World J Diabetes 2023; 14(3): 188-197 [PMID: 37035222 DOI: 10.4239/wjd.v14.i3.188]
URL: https://www.wjgnet.com/1948-9358/full/v14/i3/188.htm
Number Citing Articles
1
Stephen Z. Fadem. Understanding and Preventing Falls2023; : 5 doi: 10.1007/978-3-031-39155-2_2
2
Kyriakos Kintzoglanakis, Christos Diamantis, Anargiros Mariolis, Stavroula A Paschou. Patient-important outcomes in type 2 diabetes: The paradigm of the sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonistsDiabetes and Vascular Disease Research 2024; 21(4) doi: 10.1177/14791641241269743